Development and Validation of Analytical Methods for Radiochemical Purity of <sup>177</sup>Lu-PSMA-1

Development and Validation of Analytical Methods for Radiochemical Purity of <sup>177</sup>Lu-PSMA-1

Prostate Specific Membrane Antigen (PSMA) is a highly relevant target in nuclear medicine due to its overexpression in prostate cancer. The <sup>68</sup>Ga/<sup>177</sup>Lu-PSMA-1 combination is a theranostic agent for the detection and treatment of tumors overexpressing the...

Full description

Bibliographic Details
Main Authors: Pauline Orhon, Marie-Dominique Desruet, Marie Piquemal, Nicolas De Leiris, Loïc Djaileb, Jean-Philippe Vuillez, Pierrick Bedouch, Julien Leenhardt
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pharmaceuticals
Subjects:
radioligand therapy
prostate cancer
radiochemical purity
<sup>177</sup>Lu-PSMA-1
validation of analytical methods
high-performance liquid chromatography (HPLC)
Online Access:https://www.mdpi.com/1424-8247/15/5/522

Internet

https://www.mdpi.com/1424-8247/15/5/522

Similar Items